Wells Fargo cuts Amrize to equal-weight, PT to $44
Wells Fargo downgraded Amrize to equal-weight from overweight and cut its price target to $44.00 per share from $55.00, according to Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.